Close Menu
Home › Quest Buys Anatomic Pathology Firm PhenoPath

Quest Buys Anatomic Pathology Firm PhenoPath

Sep 27, 2018
|
staff reporter

NEW YORK (360Dx) – Quest Diagnostics announced today it has acquired specialized anatomic pathology service firm PhenoPath.

The deal, whose terms were not disclosed, continued a buying spree for Quest this week, which included the acquisitions of Oxford Immunotec's US lab business and fertility and fertility diagnostics services firm ReproSource.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Clinical Lab Management

  1. Quest Diagnostics Working With Copan to Expand Automation of Clinical Microbiology

    Premium

  2. Salveo Dx Merges With ImmunArray, Nudge

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.